|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 151 - 180 of 324 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Metronidazol Baxter 5 mg-ml infuusioneste, liuos SPC 2020-10-30
|
PL
|
Resepti
|
Metronidazole Braun 5 mg-ml infuusioneste, liuos SPC 2022-11-08
|
PL
|
Resepti
|
Metronidazole VIOSER 5 mg-ml infuusioneste, liuos SPC 2022-12-07
|
PL
|
Resepti
|
Metvix 160 mg-ml emulsiovoide SPC 2022-04-21
|
|
|
European Medicines Agency's website: Mevlyq - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Miacalcic 100 IUml injektio- ja infuusioneste, liuos SPC 2023-02-23
|
PL
|
Resepti
|
Mibg I-123 74 MBq-ml injektioneste, liuos SPC 2023-06-21
|
PL
|
Resepti
|
MIBG I-123 injektioneste, liuos SPC 2017-04-25
|
|
|
European Medicines Agency's website: Micardis - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: MicardisPlus - EMA: EPAR PI
Finnish Swedish
|
PL
|
Itsehoito
|
Microlax peräruiskeliuos SPC 2022-11-03
|
PL
|
Resepti
|
Midazolam Accord 1 mg-ml injektio-infuusioneste, liuos SPC 2024-09-04
|
PL
|
Resepti
|
Midazolam Accord 5 mg-ml injektio-infuusioneste, liuos SPC 2023-07-07
|
PL
|
Resepti
|
Midazolam Accordpharma 1 mg-ml injektio-infuusioneste, liuos, esitäytetty ruisku SPC 2024-05-27
|
PL
|
Resepti
|
Midazolam Aguettant 1 mg/ml injektioneste, liuos, esitäytetty ruisku SPC 2024-05-31
|
PL
|
Resepti
|
Midazolam hameln 1 mg-ml ja 5 mg-ml injektio-infuusioneste, liuos SPC 2023-10-11
|
PL
|
Resepti
|
Midazolam Medical Valley 2.5 mg, 5 mg, 7.5 mg, 10 mg liuos suuonteloon SPC 2023-10-30
|
PL
|
Resepti
|
Midiana 0,03mg-3mg tabletti, kalvopäällysteinen SPC 2023-01-30
|
PL
|
Resepti
|
Midodrine Tillomed 2.5 mg tabletti SPC 2024-04-23
|
PL
|
Resepti
|
Midodrine Tillomed 5 mg tabletti SPC 2024-04-23
|
PL
|
Resepti
|
Mifegyne 200 mg tabletti SPC 2024-04-10
|
PL
|
Resepti
|
Migard 2.5 mg tabletti SPC 2021-08-09
|
PL
|
Resepti
|
Miglustat Accord 100 mg kapseli, kova SPC 2023-04-05
|
|
|
European Medicines Agency's website: Miglustat Dipharma - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Miglustat Gen.Orph - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Milnocor 1 mg-ml injektio-infuusioneste, liuos SPC 2021-07-21
|
PL
|
Resepti
|
Milrinon Stragen 1 mg/ml infuusiokonsentraatti, liuosta varten SPC 2024-09-03
|
|
|
European Medicines Agency's website: Mimpara - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Mini-Pill 0.35 mg tabletti SPC 2020-04-29
|
PL
|
Itsehoito
|
Minifom 200 mg kapseli, pehmeä SPC 2022-01-28
|
|
| |